Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL

Zijun Y. Xu‐Monette(Duke University), Ken H. Young(Duke Medical Center), Michael Møller(Hospital South West Jutland), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Benjamin M. Parsons(Gundersen Health System), Maurilio Ponzoni(San Raffaele University of Rome), Ilan R. Kirsch(Adaptive Biotechnologies (United States)), Xiangshan Fan(Anhui Medical University), Eric D. Hsi(Mayo Clinic), John D. Shaughnessy(University of Arkansas for Medical Sciences), J. Han van Krieken(Radboud University Nijmegen), Bing Xu(Fujian Medical University), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Yingjun Wang(First Affiliated Hospital of Zhengzhou University), Heounjeong Go(Ulsan College), April Chiu(Mayo Clinic), Tiantian Yu(Duke Medical Center), Youli Zu(Methodist Hospital), Thomas M. Snyder(Adaptive Biotechnologies (United States)), Wayne Tam(Cornell University), Qingyan Au(NeoGenomics (United States)), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Mingzhi Zhang(Chinese Academy of Sciences), Yong Li(Baylor College of Medicine), Wenbin Qian(Ministry of Education of the People's Republic of China), Jane N. Winter(Northwestern University), Tingxun Lu(Jiangsu Province Hospital), Fredrick B. Hagemeister(The University of Texas MD Anderson Cancer Center)
Clinical Cancer Research
September 20, 2023
Cited by 19


Related Papers